5-180071500-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018434.6(RNF130):c.203C>T(p.Ala68Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
RNF130
NM_018434.6 missense
NM_018434.6 missense
Scores
1
2
16
Clinical Significance
Conservation
PhyloP100: 0.889
Genes affected
RNF130 (HGNC:18280): (ring finger protein 130) The protein encoded by this gene contains a RING finger motif and is similar to g1, a Drosophila zinc-finger protein that is expressed in mesoderm and involved in embryonic development. The expression of the mouse counterpart was found to be upregulated in myeloblastic cells following IL3 deprivation, suggesting that this gene may regulate growth factor withdrawal-induced apoptosis of myeloid precursor cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.065293044).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF130 | NM_018434.6 | c.203C>T | p.Ala68Val | missense_variant | 1/9 | ENST00000521389.6 | NP_060904.2 | |
RNF130 | NM_001410829.1 | c.203C>T | p.Ala68Val | missense_variant | 1/8 | NP_001397758.1 | ||
RNF130 | NM_001280801.2 | c.203C>T | p.Ala68Val | missense_variant | 1/8 | NP_001267730.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF130 | ENST00000521389.6 | c.203C>T | p.Ala68Val | missense_variant | 1/9 | 1 | NM_018434.6 | ENSP00000430237.1 | ||
RNF130 | ENST00000261947.4 | c.203C>T | p.Ala68Val | missense_variant | 1/8 | 1 | ENSP00000261947.4 | |||
RNF130 | ENST00000520911.5 | n.203C>T | non_coding_transcript_exon_variant | 1/9 | 1 | ENSP00000430999.1 | ||||
RNF130 | ENST00000522208.6 | c.203C>T | p.Ala68Val | missense_variant | 1/8 | 5 | ENSP00000429509.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000225 AC: 1AN: 44498Hom.: 0 AF XY: 0.0000385 AC XY: 1AN XY: 25974
GnomAD3 exomes
AF:
AC:
1
AN:
44498
Hom.:
AF XY:
AC XY:
1
AN XY:
25974
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1153098Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 554902
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1153098
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
554902
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2024 | The c.203C>T (p.A68V) alteration is located in exon 1 (coding exon 1) of the RNF130 gene. This alteration results from a C to T substitution at nucleotide position 203, causing the alanine (A) at amino acid position 68 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
0.0
.;B;.
Vest4
MutPred
Loss of ubiquitination at K67 (P = 0.0431);Loss of ubiquitination at K67 (P = 0.0431);Loss of ubiquitination at K67 (P = 0.0431);
MVP
MPC
0.67
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at